Benzodiazepine Toxicity Clinical Presentation

1. Thornton SL, Whitacre J, Pallo N, Roberts N, Oller L. A Retrospective Review of Morbidity and Mortality Associated with Acute Benzodiazepine Withdrawal at a Midwestern Academic Medical Center. Kans J Med. 2021. 14:77-79. [QxMD MEDLINE Link]. [Full Text].

2. Forster A, Gardaz JP, Suter PM, Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology. 1980 Dec. 53 (6):494-7. [QxMD MEDLINE Link]. [Full Text].

3. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005 Sep. 128 (3):1674-81. [QxMD MEDLINE Link]. [Full Text].

4. Lim TY, Poole RL, Pageler NM. Propylene glycol toxicity in children. J Pediatr Pharmacol Ther. 2014 Oct-Dec. 19 (4):277-82. [QxMD MEDLINE Link].

5. Soyka M. Treatment of Benzodiazepine Dependence. N Engl J Med. 2017 Mar 23. 376 (12):1147-1157. [QxMD MEDLINE Link].

6. Ait-Daoud N, Hamby AS, Sharma S, Blevins D. A Review of Alprazolam Use, Misuse, and Withdrawal. J Addict Med. 2018 Jan/Feb. 12 (1):4-10. [QxMD MEDLINE Link]. [Full Text].

7. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class. October 2, 2020; Accessed: April 28, 2022.

8. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: Single-dose activated charcoal. Clin Toxicol (Phila). 2005. 43(2):61-87. [QxMD MEDLINE Link].

9. Marraffa JM, Cohen V, Howland MA. Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm. 2012 Feb 1. 69(3):199-212. [QxMD MEDLINE Link].

10. Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with mixed overdose. Ann Pharmacother. 1994 Dec. 28 (12):1347-9. [QxMD MEDLINE Link].

11. Liu S, O’Donnell J, Gladden RM, McGlone L, Chowdhury F. Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines — 38 States and the District of Columbia, 2019–2020. MMWR and Morbidity and Mortality Weekly Report. 2021 Aug 27. 70:1136–1141. [Full Text].

12. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Substance Abuse and Mental Health Services Administration. Available at https://www.samhsa.gov/data/report/national-estimates-drug-related-emergency-department-visits-2004-2011-illicits-excluding. Accessed: October 2, 2021.

13. Substance Abuse and Mental Health Services Administration. Preliminary Data from the Drug Abuse Warning Network – April 2019-October 2020. SAMHSA. 2020 Oct 15. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt32809/DAWN%20Profile%20Expanded.pdf.

14. Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health. 2016 Apr. 106 (4):686-8. [QxMD MEDLINE Link]. [Full Text].

15. Santo L, Rui P, Ashman JJ. Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014-2016 National Ambulatory Medical Care Survey. Natl Health Stat Report. 2020 Jan. 1-16. [QxMD MEDLINE Link]. [Full Text].

16. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, et al. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec. 59 (12):1282-1501. [QxMD MEDLINE Link]. [Full Text].

17. European Monitoring Centre of Drugs and Drug Addiction. European Monitoring Centre of Drugs and Drug Addiction. EMCDDA.europa.eu. Available at http://www.emcdda.europa.eu/publications/pods/benzodiazepines. June 2018; Accessed: April 28, 2022.

18. Boon M, van Dorp E, Broens S, Overdyk F. Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events. Ann Palliat Med. 2020 Mar. 9 (2):542-557. [QxMD MEDLINE Link]. [Full Text].

19. Shah NA, Abate MA, Smith MJ, Kaplan JA, Kraner JC, Clay DJ. Characteristics of alprazolam-related deaths compiled by a centralized state medical examiner. Am J Addict. 2012 Nov. 21 Suppl 1:S27-34. [QxMD MEDLINE Link].

20. Isbister GK, O'Regan L, Sibbritt D, Whyte IM. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol. 2004 Jul. 58(1):88-95. [QxMD MEDLINE Link]. [Full Text].

21. Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014 Feb. 27(1):5-16. [QxMD MEDLINE Link].

22. Darke S, Torok M, Duflou J. Circumstances and toxicology of sudden or unnatural deaths involving alprazolam. Drug Alcohol Depend. 2014 May 1. 138:61-6. [QxMD MEDLINE Link].

23. [Guideline] Kleber HD, Weiss RD, Anton RF, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2006 Aug. 163(8 Suppl):5-82. [QxMD MEDLINE Link]. [Full Text].

24. [Guideline] National Collaborating Centre for Mental Health (UK). Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE). 2004. 199. [QxMD MEDLINE Link]. [Full Text].

25. Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication - A Systematic Review with Meta-Analyses of Randomised Trials. Basic Clin Pharmacol Toxicol. 2016 Jan. 118 (1):37-44. [QxMD MEDLINE Link].

26. The Flumazenil in Benzodiazepine Intoxication Multicenter Study Group. Treatment of benzodiazepine overdose with flumazenil. Clin Ther. 1992 Nov-Dec. 14(6):978-95. [QxMD MEDLINE Link].

27. Seger DL. Flumazenil--treatment or toxin. J Toxicol Clin Toxicol. 2004. 42(2):209-16. [QxMD MEDLINE Link].

28. Lembke A, Papac J, Humphreys K. Our Other Prescription Drug Problem. N Engl J Med. 2018 Feb 22. 378 (8):693-695. [QxMD MEDLINE Link]. [Full Text].

J Michael Kowalski, DO Attending Physician, Department of Emergency Medicine, Division of Medical Toxicology, Einstein Medical Center

J Michael Kowalski, DO is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, American Osteopathic Association

Disclosure: Nothing to disclose.

Laura Roper, MD Medical Toxicology Fellow, Department of Emergency Medicine, Einstein Healthcare Network

Disclosure: Nothing to disclose.

Gil Z Shlamovitz, MD, FACEP Professor of Clinical Emergency Medicine, Keck School of Medicine of the University of Southern California; Chief Medical Information Officer, Keck Medicine of USC

Gil Z Shlamovitz, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Asim Tarabar, MD Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

Chip Gresham, MD, FACEM † Emergency Medicine Physician, Medical Toxicologist, and Intensive Care Consultant, Department of Emergency Medicine, Clinical Director of Medication Safety, Middlemore Hospital; Consultant Toxicologist, National Poisons Centre; Director, Auckland Regional Toxicology Service; Senior Lecturer, Auckland University Medical School, New Zealand

Chip Gresham, MD, FACEM is a member of the following medical societies: American College of Emergency Physicians, American College of Medical Toxicology, Australasian College for Emergency Medicine, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article